A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Samaritan Medical Center has announced that its Pain Management Center will close its door at the end of next month. In an ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...